This research introduces a convolutional network that enhances ischemic stroke lesion segmentation, suggesting improved accuracy for clinical use.
Accurate segmentation of ischemic stroke lesions from multimodal magnetic resonance imaging (MRI) is fundamental for quantitative assessment, treatment planning, and outcome prediction; yet, it remains challenging due to highly heterogeneous lesion morphology, low lesion–background contrast, and substantial variability across scanners and protocols. This work introduces Tri-UNetX-2D, a large-kernel and scale-aware 2D convolutional network with explicit boundary refinement for automated ischemic stroke lesion segmentation from DWI, ADC, and FLAIR MRI. The architecture is built on a compact U-shaped encoder–decoder backbone and integrates three key components: first, a Large-Kernel Inception (LKI) module that employs factorized depthwise separable convolutions and dilation to emulate very large receptive fields, enabling efficient long-range context modeling; second, a Scale-Aware Fusion (SAF) unit that learns adaptive weights to fuse encoder and decoder features, dynamically balancing coarse semantic context and fine structural detail; and third, a Boundary Refinement Head (BRH) that provides explicit contour supervision to sharpen lesion borders and reduce boundary error. Squeeze-and-Excitation (SE) attention is embedded within LKI and decoder stages to recalibrate channel responses and emphasize modality-relevant cues, such as DWI-dominant acute core and FLAIR-dominant subacute changes. On the ISLES 2022 multi-center benchmark, Tri-UNetX-2D improves Dice Similarity Coefficient from 0.78 to 0.86, reduces the 95th-percentile Hausdorff distance from 12.4 mm to 8.3 mm, and increases the lesion-wise F1-score from 0.71 to 0.81 compared with a plain 2D U-Net trained under identical conditions. These results demonstrate that the proposed framework achieves competitive performance with substantially lower complexity than typical 3D or ensemble-based models, highlighting its potential for scalable, clinically deployable stroke lesion segmentation.
No takes yet. Share an insight, caveat, or question.
Omar Ibrahim Alirr (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: